PRA Health Sciences (PRAH) PT Raised to $108 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance
August 6, 2020 4:02 PM EDTNet new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenue
Net new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million of total revenue; representing a decrease of 4.4% at actual foreign exchange rates and 3.8% on a constant currency basisGAAP net income per diluted share of $0.22; GAAP net income of $13.9 million Adjusted net income per diluted share was $0.86; Adjusted net income of $55.2 millionFull year 2020 revenue guidance between $3.07 billion and $3.13 billion, GAAP net income per diluted share between $2.40 and $2.60 and adjusted net... More
